Search Results for keywords:"National Institute of Allergy and Infectious Diseases"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting to discuss grant applications. This meeting, scheduled for January 28, 2025, will focus on the development of tools to combat antibiotic-resistant bacteria, and it will not be open to the public to protect confidential information. The meeting will take place online and is organized by Dr. Maryam Feili-Hariri, a Scientific Review Officer at the institute.

The National Institute of Allergy and Infectious Diseases announced closed meetings scheduled for February 5, 2021. These meetings are not open to the public to protect confidential information, such as trade secrets and personal privacy. The committees will review and evaluate contract proposals related to improving technologies for large-scale high-titer phage preparations. Frank S. De Silva, Ph.D., is the contact person for these meetings.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting from May 5-7, 2025, to evaluate grant applications. The meeting will be conducted via video, following federal laws to protect confidential information about the grants and privacy of individuals. The meeting notice was issued under the Federal Advisory Committee Act, and only the necessary officials will have access due to confidentiality concerns. Contact person for the meeting is Lindsey M. Pujanandez, Ph.D.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 21-22, 2025, to discuss grant applications related to new approaches for radiation biodosimetry and medical countermeasures development. This meeting will not be open to the public to protect confidential information and personal privacy. It will be conducted virtually from 10:00 a.m. to 6:00 p.m. each day. For more information, individuals can contact Dr. Hitendra S. Chand at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting on January 9, 2025, for evaluating contract proposals related to diagnostics for specific diseases. The meeting will be held virtually at the NIAID offices in Rockville, Maryland. It will discuss sensitive information such as trade secrets and personal data, which is why it is not open to the public. Shilpakala Ketha, a Scientific Review Officer at NIAID, is the contact person for this meeting.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on March 19, 2021, from 11:30 a.m. to 2:00 p.m. The meeting is set to evaluate contract proposals and will be held virtually at the National Institutes of Health. It will remain closed to the public to protect confidential information, including trade secrets and personal data. Kelly L. Hudspeth, Ph.D., is the contact person for more details on the meeting.

The National Institute of Allergy and Infectious Diseases announced a closed meeting of its Special Emphasis Panel. This meeting, set for February 26, 2021, will focus on reviewing and evaluating grant applications without public access, as it might involve sensitive personal information and confidential data, like trade secrets and potential patents. The meeting will occur virtually, ensuring the confidentiality of the discussions. For further details, interested parties can contact Dr. Ellen S. Buczko at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting for the Microbiology, Infectious Diseases and AIDS Initial Review Group. This meeting, scheduled for April 15-17, 2025, will be conducted via video and will focus on reviewing and evaluating grant applications. The meeting is closed to the public due to potential disclosure of confidential information and personal privacy concerns. The contact person for any queries is Dr. Noton Kumar Dutta.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 28, 2025, to evaluate grant applications related to halting tuberculosis transmission. The meeting is closed to the public to protect confidential information about the grants and personal details of individuals involved. The meeting, conducted via a video-assisted format, will take place at the National Institutes of Health in Rockville, Maryland. Interested parties can contact Dr. Soheyla Saadi for more information.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 6-7, 2025. The meeting will review contract proposals related to vaccine adjuvant discovery and selection for fighting infectious and immune-mediated diseases. It will be conducted via video at their NIH office in Rockville, MD. The discussions are closed to the public to protect trade secrets and personal privacy.